{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:45:29Z","timestamp":1783633529464,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"DOI":"10.1186\/1471-2105-4-24","type":"journal-article","created":{"date-parts":[[2003,7,9]],"date-time":"2003-07-09T06:23:09Z","timestamp":1057731789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":242,"title":["A data review and re-assessment of ovarian cancer serum proteomic profiling"],"prefix":"10.1186","volume":"4","author":[{"given":"James M","family":"Sorace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,6,9]]},"reference":[{"key":"74_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0361-090X(02)00092-2","volume":"26","author":"CM Michener","year":"2002","unstructured":"Michener CM, Ardekani AM, Petricoin EF 3rd, Liotta LA, Kohn EC: Genomics and proteomics: application of novel technology to early detection and prevention of cancer.\n                           Cancer Detect Prev 2002, 26: 249\u2013255. 10.1016\/S0361-090X(02)00092-2","journal-title":"Cancer Detect Prev"},{"key":"74_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrd891","volume":"1","author":"EF Petricoin","year":"2002","unstructured":"Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA: Clinical proteomics: translating benchside promise into bedside reality.\n                           Nat Rev Drug Discov 2002, 1: 683\u2013695. 10.1038\/nrd891","journal-title":"Nat Rev Drug Discov"},{"key":"74_CR3","first-page":"1160","volume":"48","author":"PR Srinivas","year":"2002","unstructured":"Srinivas PR, Verma M, Zhao Y, Srivastava S: Proteomics for cancer biomarker discovery.\n                           Clin Chem 2002, 48: 1160\u20131169.","journal-title":"Clin Chem"},{"key":"74_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1155\/2001\/327047","volume":"17","author":"PC Herrmann","year":"2001","unstructured":"Herrmann PC, Liotta LA, Petricoin EF 3rd: Cancer proteomics: the state of the art.\n                           Dis Markers 2001, 17: 49\u201357.","journal-title":"Dis Markers"},{"key":"74_CR5","unstructured":"Clinical Proteomics Data Bank[http:\/\/clinicalproteomics.steem.com\/ppatterns.php]"},{"key":"74_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","volume":"359","author":"EF Petricoin","year":"2002","unstructured":"Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer.\n                           Lancet 2002, 359: 572\u2013577. 10.1016\/S0140-6736(02)07746-2","journal-title":"Lancet"},{"key":"74_CR7","unstructured":"Clinical Proteomics Data Bank[http:\/\/clinicalproteomics.steem.com\/download-ovar.php]"},{"key":"74_CR8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.5858\/2002-126-1518-PATTMD","volume":"126","author":"AJ Rai","year":"2002","unstructured":"Rai AJ, Zhang Z, Rosenzweig J, Shih IeM, Pham T, Fung ET, Sokoll LJ, Chan DW: Proteomic Approaches to tumor marker discovery.\n                           Arch Pathol Lab Med 2002, 126: 1518\u201326.","journal-title":"Arch Pathol Lab Med"},{"key":"74_CR9","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1093\/jnci\/94.20.1576","volume":"94","author":"EF Petricoin 3rd","year":"2002","unstructured":"Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA: Serum proteomic patterns for detection of prostate cancer.\n                           J Natl Cancer Inst 2002, 94: 1576\u20131578. 10.1093\/jnci\/94.20.1576","journal-title":"J Natl Cancer Inst"},{"key":"74_CR10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/clinchem\/48.10.1835","volume":"48","author":"Y Qu","year":"2002","unstructured":"Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL Jr: Boosted decision tree analysis of surface-enhanced laser desorption\/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.\n                           Clin Chem 2002, 48: 1835\u20131843.","journal-title":"Clin Chem"},{"key":"74_CR11","first-page":"2541","volume":"8","author":"LH Cazares","year":"2002","unstructured":"Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL Jr: Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption\/ionization mass spectrometry.\n                           Clin Cancer Res 2002, 8: 2541\u20132552.","journal-title":"Clin Cancer Res"},{"key":"74_CR12","first-page":"3609","volume":"62","author":"BL Adam","year":"2002","unstructured":"Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr: Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.\n                           Cancer Res 2002, 62: 3609\u20133614.","journal-title":"Cancer Res"},{"key":"74_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/1615-9861(200110)1:10<1264::AID-PROT1264>3.0.CO;2-R","volume":"1","author":"BL Adam","year":"2001","unstructured":"Adam BL, Vlahou A, Semmes OJ, Wright GL Jr: Proteomic approaches to biomarker discovery in prostate and bladder cancers.\n                           Proteomics 2001, 1: 1264\u20131270. Publisher Full Text 10.1002\/1615-9861(200110)1:10<1264::AID-PROT1264>3.3.CO;2-I","journal-title":"Proteomics"},{"key":"74_CR14","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/S0002-9440(10)64100-4","volume":"58","author":"A Vlahou","year":"2001","unstructured":"Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright GL Jr: Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.\n                           Am J Pathol 2001, 58: 1491\u20131502.","journal-title":"Am J Pathol"},{"key":"74_CR15","unstructured":"Baggerly KA, Morris JS, Wang J, Gold D, Xiao LC, Coombes KR: A comprehensive Approach to the analysis of MALDI-TOF proteomics spectra from serum samples.\n                           Proteomics, in press."},{"key":"74_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jama.280.8.719","volume":"280","author":"Y Xu","year":"1998","unstructured":"Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, Kennedy AW, Belinson J, Markman M, Casey G: Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.\n                           JAMA 1998, 280: 719\u2013723. 10.1001\/jama.280.8.719","journal-title":"JAMA"},{"key":"74_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1071-5576(00)00092-7","volume":"8","author":"Y Xu","year":"2001","unstructured":"Xu Y, Xiao YJ, Baudhuin LM, Schwartz BM: The role and clinical applications of bioactive lysolipids in ovarian cancer.\n                           J Soc Gynecol Investig 2001, 8: 1\u201313. 10.1016\/S1071-5576(00)00092-7","journal-title":"J Soc Gynecol Investig"},{"key":"74_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/abio.2001.5000","volume":"290","author":"YJ Xiao","year":"2001","unstructured":"Xiao YJ, Schwartz B, Washington M, Kennedy A, Webster K, Belinson J, Xu Y: Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.\n                           Anal Biochem 2001, 290: 302\u2013313. 10.1006\/abio.2001.5000","journal-title":"Anal Biochem"},{"key":"74_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1749-6632.2000.tb06554.x","volume":"905","author":"Y Xiao","year":"2000","unstructured":"Xiao Y, Chen Y, Kennedy AW, Belinson J, Xu Y: Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI-MS) Analysis.\n                           Ann N Y Acad Sci 2000, 905: 242\u2013259.","journal-title":"Ann N Y Acad Sci"},{"key":"74_CR20","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1001\/jama.287.23.3081","volume":"287","author":"DL Baker","year":"2002","unstructured":"Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, Bonfrer JM, Bais E, Moolenaar WH, Tigyi G: Plasma lysophosphatidic acid concentration and ovarian cancer.\n                           JAMA 2002, 287: 3081\u20133082. 10.1001\/jama.287.23.3081","journal-title":"JAMA"},{"key":"74_CR21","unstructured":"Atairgin Technologies Inc[http:\/\/www.atairgin.com\/atairgin.htm]"},{"key":"74_CR22","unstructured":"What is Perimenopause?[http:\/\/www.menopause-online.com\/pmsormenopause.html]"},{"key":"74_CR23","unstructured":"SAS Institute Inc., SAS\/STAT User's Guide, Version 8, DISCRIM procedure, Pages 1011\u20131119, NPAR1WAY procedure, Pages 2505\u20132552, and STEPDISC procedure, Pages 3153\u20133179, Cary, NC: SAS Institute Inc. 1999."},{"key":"74_CR24","unstructured":"Clinical Proteomics Program Database Detailed explanation of Proteome Quest for data analysis[http:\/\/clinicalproteomics.steem.com\/proteome-detail.php]"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-4-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:56:19Z","timestamp":1726242979000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-4-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-4-24","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,9]]},"assertion":[{"value":"28 March 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"24"}}